You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

WTX-330

Showing 1 - 25 of 145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Non-Hodgkin Lymphoma
  • WTX-330
  • San Antonio, Texas
    NEXT Oncology
Jan 6, 2023

Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (WTX-124, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumor
  • Advanced Solid Tumor
  • Scottsdale, Arizona
  • +4 more
Aug 3, 2022

Corneal Thinning, Keratoconus Trial in Pittsburgh (Pulsed or continuous lighting)

Not yet recruiting
  • Corneal Thinning
  • Keratoconus
  • Pulsed or continuous lighting
  • Pittsburgh, Pennsylvania
    UPMC Eye Center
Aug 3, 2022

Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome Trial in Worldwide (AMG 330)

Terminated
  • Relapsed/Refractory AML
  • +2 more
  • AMG 330
  • Birmingham, Alabama
  • +10 more
Nov 9, 2022

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • (no location specified)
Jan 19, 2023

Atopic Dermatitis Trial in Canada, China (Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active

Recruiting
  • Atopic Dermatitis
  • Core Treatment Active Experimental: SHR0302 Dose#1
  • +4 more
  • Surrey, British Columbia, Canada
  • +43 more
Oct 31, 2022

Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Ectasia Trial in San Francisco (PXL-330 Platinum device for

Recruiting
  • Keratoconus
  • +2 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • San Francisco, California
    Goodman Eye Center
Aug 19, 2022

Keratitis, Corneal Ulcer Trial in United States (Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care

Recruiting
  • Keratitis
  • Corneal Ulcer
  • Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution
  • Standard of Care Therapy + Sham CXL + Artificial Tears
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial

Recruiting
  • Keratitis
  • Corneal Ulcer
  • PXL Platinum 330 system + Riboflavin 0.25% TE Solution
  • Sham CXL + Artificial Tears
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration Trial in Dallas (PXL-330 Platinum device for

Recruiting
  • Keratoconus
  • +3 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • Dallas, Texas
    Cornea Associates of Texas
Mar 7, 2022

Keratoconus, Cornea Ectasia Trial in Orland Park (Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system.)

Recruiting
  • Keratoconus
  • Cornea Ectasia
  • Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system.
  • Orland Park, Illinois
    Arbor Center for Eye Care
Mar 16, 2022

Alopecia Areata Trial in China (SHR0302, Placebo)

Recruiting
  • Alopecia Areata
  • Hefei, Anhui, China
  • +31 more
Jul 21, 2022

Pulmonary Embolism Trial in Lørenskog (Low iodine Spectral Detector CT Pulmonary Angiography)

Completed
  • Pulmonary Embolism
  • Low iodine Spectral Detector CT Pulmonary Angiography
  • Lørenskog, Viken, Norway
    Akershus University Hospital
Nov 24, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
Has Results
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Corneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration Trial in Littleton, Highland Park, Brecksville (PXL-330

Recruiting
  • Corneal Ectasia
  • +2 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • Littleton, Colorado
  • +2 more
Jan 24, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Physical Inactivity Trial in Providence (Monetary Incentives)

Not yet recruiting
  • Physical Inactivity
  • Monetary Incentives
  • Providence, Rhode Island
    Brown University
Jan 27, 2023

ADHD, ADD Trial in Karasjok, Tromsø (Calanus oil, Medical Paraffin)

Recruiting
  • ADHD
  • ADD
  • Calanus oil
  • Medical Paraffin
  • Karasjok, Finnmark, Norway
  • +1 more
Jan 4, 2023

Dysmenorrhea Primary, Menstrual Pain, Ibuprofen Trial in Banda Aceh (Ibuprofen 400 mg, Young Coconut Water, Dark Chocolate Bar)

Completed
  • Dysmenorrhea Primary
  • +2 more
  • Ibuprofen 400 mg
  • +2 more
  • Banda Aceh, Aceh, Indonesia
    Saleha Academy of Midwifery
Aug 1, 2023

Relapsed or Refractory Acute Myeloid Leukemia Trial in Duarte, Houston (AMG 330, Pembrolizumab)

Terminated
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Duarte, California
  • +1 more
Dec 2, 2021

Keratoconus, Unstable, Bacterial Keratitis, Ectasia of Cornea Trial in Eugene (PXL-330 Platinum device for crosslinking with

Recruiting
  • Keratoconus, Unstable
  • +2 more
  • PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution
  • Eugene, Oregon
    Pacific Clear Vision Institute
Sep 14, 2021

Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

Withdrawn
  • Solid Tumor Malignancy
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
Dec 14, 2021

Keratoconus, Unstable, Ectasia Corneal, Bacterial Keratitis Trial in Indianapolis (PXL 330 Platinum device/Riboflavin)

Recruiting
  • Keratoconus, Unstable
  • +2 more
  • PXL 330 Platinum device/Riboflavin
  • Indianapolis, Indiana
    Eye Specialists of Indiana
Aug 16, 2021

Control arm_Bolstered Care, Treatment arm_HIVRR+S+FL, Treatment arm_HIVRR+S+FLM Trial in Masaka (HIV Risk Reduction, Financial

Active, not recruiting
  • Control arm_Bolstered Care
  • +2 more
  • HIV Risk Reduction
  • +3 more
  • Masaka, Uganda
    International Center for Child Health and Development Field Offi
May 10, 2022

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
Has Results
  • Glioblastoma
  • Glioma
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023